Abstract: The present disclosure provides combined adjuvants nanoparticles prepared by self-assembly with amphiphilic monomer molecules as the building blocks, wherein the amphiphilic monomer molecules are generated from the reaction between hydrophobic adjuvants molecules and hydrophilic adjuvants molecules.
Type:
Application
Filed:
June 17, 2020
Publication date:
August 4, 2022
Applicant:
INSTITUTE OF BIOMEDICAL ENGINEERING, CHINESE ACADEMY OF MEDICAL SCIENCES
Inventors:
LANXIA LIU, DAN LIU, JIALE LIU, XIGANG LENG
Abstract: The invention discloses a use of paracetamol and a pharmaceutical preparation containing the same in preparation of anti-HPV drugs. The novel anti-HPV pharmaceutical preparation of the invention has a significant anti-HPV effect and low toxicity, and can be used for preventing and treating clinical symptoms caused by HPV infection, especially common warts, plane warts, plantar wart, vulvar cancer, penile neoplasms, anal carcinoma, prostate cancer, bladder cancer, cervical cancer, rectal cancer, oral cancer, tonsil cancer and the like.
Type:
Grant
Filed:
July 14, 2014
Date of Patent:
August 14, 2018
Assignee:
INSTITUTE OF BIOMEDICAL ENGINEERING, CHINESE ACADEMY OF MEDICAL SCIENCE
Inventors:
Tianjun Liu, Shuai Meng, Lihui Zhao, Ge Hong